Home › Funds › Affinity Asset Advisors, LLC › BLTE

Affinity Asset Advisors, LLC position in BLTE

BELITE BIO INC · Health Care

Affinity Asset Advisors, LLC reported holding 242,088 shares of BLTE (BELITE BIO INC) in its Q3 2026 13F filing — a position valued at US$41.1M, representing 1.91% of its reported portfolio and ranking #15 among its reported holdings. Affinity Asset Advisors, LLC has disclosed BLTE holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)242.09K sh
Reported value held$41.11M
Portfolio Weight1.91%
First reportedQ4 2025
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Affinity Asset Advisors, LLC's BLTE position evolved

Affinity Asset Advisors, LLC first disclosed a stake in BLTE in Q4 2025 at 20,000 shares (US$3.2M). The position peaked in Q3 2026 at 242,088 shares, worth US$41.1M. Across 4 filings, Affinity Asset Advisors, LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 242,088 shares valued at US$41.1M — an increase of 77,088 shares quarter over quarter.. Notable position changes include a 225% increase in Q1 2026 (shares fell 3% over the following quarter), a 154% increase in Q2 2026 (shares rose 10% over the following quarter), a 47% increase in Q3 2026 (shares fell 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 20.00K $3.20M New
Q1 2026 65.00K $10.36M Add
Q2 2026 165.00K $25.41M Add
Q3 2026 242.09K $41.11M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BLTE and 13F data

BLTE (BELITE BIO INC) is a Health Care company. 73 other funds we track also report a position in BLTE — the largest reported positions include Darwin Global Management, Ltd. (US$456.6M), Paradigm Biocapital Advisors LP (US$189.8M), RTW INVESTMENTS, LP (US$110.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BLTE

All BLTE fund holders →

FAQ

How long has Affinity Asset Advisors, LLC held BLTE?

Affinity Asset Advisors, LLC has disclosed BLTE holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Affinity Asset Advisors, LLC's current position in BLTE?

As of Q3 2026, Affinity Asset Advisors, LLC holds 242.09K shares of BLTE (BELITE BIO INC), valued at $41.11M, representing 1.91% of its reported portfolio and ranking #15.

Has Affinity Asset Advisors, LLC been buying or selling BLTE?

In the latest 13F filing (Q3 2026), Affinity Asset Advisors, LLC increased its position in BLTE. The position peaked in Q3 2026 at 242.09K shares.

Which other funds hold BLTE?

Other major institutional holders of BLTE include Darwin Global Management, Ltd., Paradigm Biocapital Advisors LP, RTW INVESTMENTS, LP, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.